Frontlight ResearchEarly access
Trial site
Envision Trials LLC
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease5 trials
- Schizophrenia3 trials
- Phase
- Phase 33 trials
- Phase 22 trials
- Status
- Recruiting6 trials
- Lead sponsor
- Bristol-Myers Squibb2 trials
- Intra-Cellular Therapies, Inc.2 trials
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 trials
Running trials
Recruiting
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Recruiting
Recruiting
Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease5 recruiting
- Schizophrenia3 recruiting
Site data: ClinicalTrials.govUpdated 13 Nov 2026